Abstract
The rennin–angiotensin–aldosterone system (RAAS) is a critical pathway in regulating blood pressure and salt/water homeostasis, possessing an intimate relationship with the development of systemic artery hypertension (SAH). Once hypertension is considered a risk factor for coronary artery disease (CAD), the RAAS is also related to this pathology. This investigation aimed to analyse if the frequencies of AGT M235T (rs699) and ACE I/D (rs4646994) polymorphisms are associated with CAD and SAH in African-Brazilians and Caucasian-Brazilians. In this study we analysed 714 subjects who underwent coronary angiography to detect obstructive lesions and CAD, as well as blood pressure measurement and SAH, grouped according to ethnicity: 266 African-Brazilians and 448 Caucasian-Brazilians. Among CAD and SAH cases and controls, the genotype and allele frequencies of ACE I/D polymorphism were similar in both ethnic groups. The AGT 235TT genotype and 235T allele frequencies were higher in SAH cases (32%, 54.7%) versus controls in Caucasian-Brazilians (19.8%, 46.4%; P= 0.038, P= 0.031, respectively). The AGT 235TT (OR = 1.8; P= 0.028) demonstrated to be an independent factor risk in a multivariate logistic regression increasing SAH risk in Caucasians but not in African-Brazilians. In summary, AGT M235T polymorphism was associated with SAH risk in Caucasian-Brazilians, and no association was detected with CAD. No association was also observed in ACE I/D polymorphism either in CAD or SAH in African-Brazilians and Caucasian-Brazilians.
Similar content being viewed by others
References
Abramson J. H. 2004 WINPEPI (PEPI-for-Windows): computer programs for epidemiologists. Epidemiol. Perspect. Innov. 1, 6.
Azevédo E. S. 1980 Subgroup studies of black admixture within a mixed population of Bahia, Brazil. Ann. Hum. Genet. 44, 55–60.
Bautista L. E., Vargas C. I., Oróstegui M. and Gamarra G. 2008 Population-based case–control study of renin–angiotensin system genes polymorphisms and hypertension among Hispanics. Hypertens. Res. 31, 401–408.
Burrell L. M., Harrap S. B., Velkoska E. and Patel S. K. 2013 The ACE2 gene: its potential as a functional candidate for cardiovascular disease. Clin. Sci. 124, 65–76.
Caulfield M., Lavender P., Newell-Price J., Farrall M., Kamdar S., Daniel H. et al. 1995 Linkage of the angiotensinogen gene locus to human essential hypertension in African Caribbeans. J. Clin. Invest. 96, 687–692.
Conen D., Glynn R. J., Buring J. E., Ridker P. M. and Zee R. Y. L. 2008 Association of renin–angiotensin and endothelial nitric oxide synthase gene polymorphisms with blood pressure progression and incident hypertension: prospective cohort study. J. Hypertens. 26, 1780–1786.
Cooper R. and Rotimi C. 1997 Hypertension in blacks. Am. J. Hypertens. 10, 804–812.
Danilczyk U. and Penninger J. M. 2006 Angiotensin-converting enzyme II in the heart and the kidney. Circ. Res. 98, 463– 471.
De Schutter A., Lavie C. J. and Milani R. V. 2014 The impact of obesity on risk factors and prevalence and prognosis of coronary heart disease–the obesity paradox. Prog. Cardiovasc. Dis. 56, 401–408.
Dustan H. P. 1974 Atherosclerosis complicating chronic hypertension. Circulation 50, 871–879.
Ellis K. L., Palmer B. R., Frampton C. M., Troughton R. W., Doughty R. N., Whalley G. A. et al. 2013 Genetic variation in the renin–angiotensin–aldosterone system is associated with cardiovascular risk factors and early mortality in established coronary heart disease. J. Hum. Hypertens. 27, 237–244.
Eriksson H. 1995 Heart failure: a growing public health problem. J. Int. Med. 237, 135–141.
Friedewald W. T., Levy R. I. and Fredrickson D. S. 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502.
Fruchart J.-C., Nierman M. C., Stroes E. S. G., Kastelein J. J. P. and Duriez P. 2004 New risk factors for atherosclerosis and patient risk assessment. Circulation 109, III15–III19.
Gardemann A., Fink M., Stricker J., Nguyen Q. D., Humme J., Katz N. et al. 1998 ACE I/D gene polymorphism: presence of the ACE D allele increases the risk of coronary artery disease in younger individuals. Atherosclerosis 139, 153–159.
Gluba A., Banach M., Mikhailidis D. P. and Rysz J. 2009 Genetic determinants of cardiovascular disease: the renin–angiotensin–aldosterone system, paraoxonases, endothelin-1, nitric oxide synthase and adrenergic receptors. In Vivo 23, 797– 812.
Guney A. I., Ergec D., Kirac D., Ozturhan H., Caner M., Koc G. et al. 2013 Effects of ACE polymorphisms and other risk factors on the severity of coronary artery disease. Genet. Mol. Res. 12, 6895–6906.
Jeunemaitre X., Soubrier F., Kotelevtsev Y. V., Lifton R. P., Williams C. S., Charru A. et al. 1992 Molecular basis of human hypertension: role of angiotensinogen. Cell 71, 169–180.
Kannel W. B., Gordon T. and Schwartz M. J. 1971 Systolic versus diastolic blood pressure and risk of coronary heart disease. Am. J. Cardiol. 27, 335–346.
Kato N. 2002 Genetic analysis in human hypertension. Hypertens. Res. 25, 319–327.
Laragh J. H., Baer L., Brunner H. R., Buhler F. R., Sealey J. E. and Vaughan E. D. 1972 Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am. J. Med. 52, 633–652.
Martinez Cantarin M. P., Ertel A., Deloach S., Fortina P., Scott K., Burns T. L. et al. 2010 Variants in genes involved in functional pathways associated with hypertension in African Americans. Clin. Trans. Sci. 3, 279–286.
McPherson R. and Davies R. W. 2012 Inflammation and coronary artery disease: insights from genetic studies. Can. J. Cardiol. 28, 662–666.
Mehri S., Mahjoub S., Hammami S., Zaroui A., Frih A., Betbout F. et al. 2012 Renin–angiotensin system polymorphisms in relation to hypertension status and obesity in a Tunisian population. Mol. Biol. Rep. 39, 4059–4065.
Meroufel D. N., Médiène-Benchekor S., Dumont J., Benhamamouch S., Amouyel P. and Brousseau T. 2014 A study on the polymorphisms of the renin–angiotensin system pathway genes for their effect on blood pressure levels in males from Algeria. J. Renin Angiotensin Aldosterone Sys. 15, 1–6.
Miyama N., Hasegawa Y., Suzuki M., Hida W., Kazama I., Hatano R. et al. 2007 Investigation of major genetic polymorphisms in the renin–angiotensin–aldosterone system in subjects with young-onset hypertension selected by a targeted-screening system at university. Clin. Exp. Hypertens. 29, 61–67.
Moradzadegan A., Vaisi-Raygani A., Nikzamir A. and Rahimi Z. 2014. Angiotensin-converting enzyme insertion/deletion (I/D) (rs4646994) and Vegf polymorphism (+ 405G/C; rs2010963) in type II diabetic patients: association with the risk of coronary artery disease. J. Renin Angiotensin Aldosterone Sys. 16 672–680.
Ned R. M., Yesupriya A., Imperatore G., Smelser D. T., Moonesinghe R., Chang M. H. et al. 2012 The ACE I/D polymorphism in US adults: limited evidence of association with hypertension-related traits and sex-specific effects by race/ethnicity. Am. J. Hypertens. 25, 209–215.
Paillard F., Chansel D., Brand E., Benetos A., Thomas F., Czekalski S. et al. 1999 Genotype–phenotype relationships for the renin–angiotensin–aldosterone system in a normal population. Hypertension 34, 423–429.
Pandey U., Kumari R., Nath B., Ganesh S., Banerjee I., Hasan O. M. et al. 2011 Association of angiotensin-converting enzyme, methylene tetrahydrofolate reductase and paraoxonase gene polymorphism and coronary artery disease in an Indian population. Cardiol. J. 18, 385–394.
Procopciuc L., Popescu T., Jebeleanu G., Pop D. and Zdrenghea D. 2002 Essential arterial hypertension and polymorphism of angiotensinogen M235T gene. J. Cell. Mol. Med. 6, 245– 250.
Re R. N. 2004 Mechanisms of disease: local renin–angiotensin–aldosterone systems and the pathogenesis and treatment of cardiovascular disease. Nat. Clin. Pract. Cardiovasc. Med. 1, 42–47.
Rigat B., Hubert C., Alhenc-Gelas F., Cambien F., Corvol P. and Soubrier F. 1990 An insertion/deletion polymorphism in the angiotensin I-converting enzyme gene accounting for half the variance of serum enzyme levels. J. Clin. Invest. 86, 1343– 1346.
Rios D. L. S., D’Onofrio L. O., Cerqueira C. C. S., Bonfim-Silva R., Carvalho H. G., Santos-Filho A. et al. 2007a Paraoxonase 1 gene polymorphisms in angiographically assessed coronary artery disease: evidence for gender interaction among Brazilians. Clin. Chem. Lab. Med. 45, 874–878.
Rios D. L. S., D’Onofrio L. O., Souza J. K., Queiroz A. M., Raduy-Maron L., Silva-Neto N. et al. 2007b Smoking-dependent and haplotype-specific effects of endothelial nitric oxide synthase gene polymorphisms on angiographically-assessed coronary artery disease in Caucasian- and African-Brazilians. Atherosclerosis 193, 135–141.
Rios D. L. S., Cerqueira C. C. S., Bonfim-Silva R., Araújo L. J., Pereira J. F., Gadelha S. R. et al. 2010 Interleukin-1 beta and interleukin-6 gene polymorphism associations with angiographically assessed coronary artery disease in Brazilians. Cytokine 50, 292–296.
Rotimi C., Puras A., Cooper R., McFarlane-Anderson N., Forrester T., Ogunbiyi O. et al. 1996 Polymorphisms of renin–angiotensin genes among Nigerians, Jamaicans, and African Americans. Hypertension 27, 558–563.
Santos P. C. J. L., Alvim R. O., Ferreira N. E., Cunha R. S., Krieger J. E., Mill J. G. et al. 2011 Ethnicity and arterial stiffness in Brazil. Am. J. Hypertens. 24, 278–284.
Schneider I. 2000 Software programs for DNA sequence analysis. Genet. Eng. News 20, 8.
Sethi A. A., Nordestgaard B. G. and Tybjaerg-Hansen A. 2003 Angiotensinogen gene polymorphism, plasma angiotensinogen, and risk of hypertension and ischemic heart disease: a meta-analysis. Arterioscler. Thromb. Vasc. Biol. 23, 1269– 1275.
Tsai C. T., Hwang J. J., Ritchie M. D., Moore J. H., Chiang F. T., Lai L. P. et al. 2011 Renin–angiotensin system gene polymorphisms and coronary artery disease in a large angiographic cohort: detection of high order gene–gene interaction. Atherosclerosis 195, 172–180.
Van den Born B.-J. H., Van Montfrans G. A., Uitterlinden A. G., Zwinderman A. H. and Koopmans R. P. 2007 The M235T polymorphism in the angiotensinogen gene is associated with the risk of malignant hypertension in white patients. J. Hypertens. 25, 2227–2233.
Wilson P. W. F., D’Agostino R. B., Levy D., Belanger A. M., Silbershatz H. and Kannel W. B. 1998 Prediction of coronary heart disease using risk factor categories. Circulation 97, 1837–1847.
Ying C.-Q., Wang Y.-H., Wu Z.-L., Fang M.-W., Wang J., Li Y.-S. et al. 2010 Association of the renin gene polymorphism, three angiotensinogen gene polymorphisms and the haplotypes with essential hypertension in the Mongolian population. Clin. Exp. Hypertens. 32, 293–300.
Acknowledgements
This study was supported by the Fundação de Amparo à Pesquisa do Estado da Bahia (FAPESB) and by the Conselho Nacional de Desenvolvimento Científico e Tecnológico (CNPq).
Author information
Authors and Affiliations
Corresponding author
Additional information
[Bonfim-Silva R., Guimarães L. O., Santos J. S., Pereira J. F., Barbosa A. A. L. and Rios D. L. S. 2016 Case–control association study of polymorphisms in the angiotensinogen and angiotensin-converting enzyme genes and coronary artery disease and systemic artery hypertension in African-Brazilians and Caucasian-Brazilians. J. Genet. 95, xx–xx]
Rights and permissions
About this article
Cite this article
BONFIM-SILVA, R., GUIMARÃES, L.O., SANTOS, J.S. et al. Case–control association study of polymorphisms in the angiotensinogen and angiotensin-converting enzyme genes and coronary artery disease and systemic artery hypertension in African-Brazilians and Caucasian-Brazilians. J Genet 95, 63–69 (2016). https://doi.org/10.1007/s12041-015-0599-5
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s12041-015-0599-5